Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roderick E Hubbard

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Chemical Science|October 3, 2025
Design, modular synthesis and screening of 58 shape-diverse 3-D fragmentsThomas D Downes, S Paul Jones, James D Firth, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 22, 2020
Design and Synthesis of 56 Shape-Diverse 3D FragmentsThomas D Downes, S Paul Jones, Hanna F Klein, et al.
RSC Medicinal Chemistry|December 18, 2023
A covalent fragment-based strategy targeting a novel cysteine to inhibit activity of mutant EGFR kinaseNaoki Kuki, David L Walmsley, Kazuo Kanai, et al.
Journal of Medicinal Chemistry|July 25, 2019
Structure-Guided Discovery of a Selective Mcl-1 Inhibitor with Cellular ActivityZoltan Szlávik, Levente Ondi, Márton Csékei, et al.
ACS Omega|August 29, 2019
Establishing Drug Discovery and Identification of Hit Series for the Anti-apoptotic Proteins, Bcl-2 and Mcl-1James B Murray, James Davidson, Ijen Chen, et al.
Journal of Medicinal Chemistry|November 4, 2020
Discovery of S64315, a Potent and Selective Mcl-1 InhibitorZoltan Szlavik, Marton Csekei, Attila Paczal, et al.
Journal of Medicinal Chemistry|October 13, 2017
Design of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Crystallographic Surrogate Derived from Checkpoint Kinase 1 (CHK1)Douglas S Williamson, Garrick P Smith, Pamela Acheson-Dossang, et al.
Journal of Medicinal Chemistry|November 19, 2020
Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial ActivityYousuke Yamada, Hajime Takashima, David Lee Walmsley, et al.
Journal of Medicinal Chemistry|June 12, 2026
Structure-Based Discovery of Potent BCL-XL Inhibitors through RescaffoldingMatyas Pal Timari, Attila Paczal, Andras Herner, et al.
Molecular Cancer Therapeutics|April 14, 2007
Inhibition of the heat shock protein 90 molecular chaperone in vitro and in vivo by novel, synthetic, potent resorcinylic pyrazole/isoxazole amide analoguesSwee Y Sharp, Chrisostomos Prodromou, Kathy Boxall, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Chemical Science|October 3, 2025
Design, modular synthesis and screening of 58 shape-diverse 3-D fragmentsThomas D Downes, S Paul Jones, James D Firth, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 22, 2020
Design and Synthesis of 56 Shape-Diverse 3D FragmentsThomas D Downes, S Paul Jones, Hanna F Klein, et al.
RSC Medicinal Chemistry|December 18, 2023
A covalent fragment-based strategy targeting a novel cysteine to inhibit activity of mutant EGFR kinaseNaoki Kuki, David L Walmsley, Kazuo Kanai, et al.
Journal of Medicinal Chemistry|July 25, 2019
Structure-Guided Discovery of a Selective Mcl-1 Inhibitor with Cellular ActivityZoltan Szlávik, Levente Ondi, Márton Csékei, et al.
ACS Omega|August 29, 2019
Establishing Drug Discovery and Identification of Hit Series for the Anti-apoptotic Proteins, Bcl-2 and Mcl-1James B Murray, James Davidson, Ijen Chen, et al.
Journal of Medicinal Chemistry|November 4, 2020
Discovery of S64315, a Potent and Selective Mcl-1 InhibitorZoltan Szlavik, Marton Csekei, Attila Paczal, et al.
Journal of Medicinal Chemistry|October 13, 2017
Design of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Crystallographic Surrogate Derived from Checkpoint Kinase 1 (CHK1)Douglas S Williamson, Garrick P Smith, Pamela Acheson-Dossang, et al.
Journal of Medicinal Chemistry|November 19, 2020
Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial ActivityYousuke Yamada, Hajime Takashima, David Lee Walmsley, et al.
Journal of Medicinal Chemistry|June 12, 2026
Structure-Based Discovery of Potent BCL-XL Inhibitors through RescaffoldingMatyas Pal Timari, Attila Paczal, Andras Herner, et al.
Molecular Cancer Therapeutics|April 14, 2007
Inhibition of the heat shock protein 90 molecular chaperone in vitro and in vivo by novel, synthetic, potent resorcinylic pyrazole/isoxazole amide analoguesSwee Y Sharp, Chrisostomos Prodromou, Kathy Boxall, et al.
Pageof 8